EPO and primary progressive multiple sclerosis: The pronounced upregulation of hS3 mRNA under ischemia- and inflammation-related conditions (e.g., stroke, PPMS) emphasizes the functional importance of EPO alternative splicing in adapting to stress-related functional demands of the cell.